You’re in your doctor’s office, looking over your latest bloodwork. Your HbA1c (A1c) comes back at 5.7, and the doctor smiles—“You’re fine for now, but let’s keep an eye on it.” Still, something about it sticks with you. What does that number actually mean? What if it’s not fine at all—what if it’s just the tip of something bigger?

The surface may look calm, but below it, an iceberg of metabolic damage is quietly taking shape. Your A1c result is just the visible tip of that iceberg—a snapshot of sugar in the bloodstream. Beneath the surface lies the older ice of glycation—neurons, vascular walls, and structural proteins slowly accumulating damage over time. As the iceberg sinks deeper, it traps rocks, sediment, and pockets of ancient gas—just as glycation traps waste products, inflammation, and oxidative stress in slow-turnover tissues. What we see in the blood reflects the last few months of sugar exposure—it’s relatively recent and reversible. What lies below represents years of slow, cumulative injury in deeper tissues—older damage that’s far harder to move.

Glycation happens when sugar binds to proteins, lipids, or DNA—warping their shape and function, often permanently. Once a molecule is glycated, there’s no undoing it. The only fix comes through turnover: breaking down damaged cells and rebuilding new ones. Fast-renewing tissues like skin and liver can recover quickly, while slow-turnover systems—cartilage, nerve tissue, vascular endothelium—carry that burden for years. Less sugar means slower glycation, giving your body’s renewal cycles a chance to keep pace. That’s the essence of glycation: chemistry that quietly determines your future resilience or your decline.

A1c is the fingerprint of that chemistry. It’s the share of your red blood cells’ hemoglobin bonded with glucose—a 90-day snapshot of how sugary your blood has been. Clinically, anything below 5.7 % is considered normal. In practice, we often see athletes closer to 5.1–5.3 %, which may reflect better fuel regulation and nutritional tolerance.

A1c captures only what’s visible above the surface.. It shows what’s happening in your blood, but not what’s occurred in your brain, joints, or nerves. Beneath the surface, glycation from glucose and fructose is already corroding performance, recovery, and long-term health.

Each blood sugar spike—every processed carb or sweet treat—adds another microscopic layer of glycation your body has to repair. These reactions occur both in the bloodstream and along vessel walls and connective tissue, where glycation creates crosslinks that stiffen and weaken those structures over time.  This process contributes to the vascular stiffness and metabolic wear that mark early chronic disease.

That’s what your A1c captures—a 90-day record of sugar exposure, reflecting the average lifespan of a red blood cell. It tells the story of how consistently your blood has carried glucose, rather than moment-to-moment spikes. But it only shows part of the chemistry. Glucose bonds directly to hemoglobin, forming measurable glycated blood (A1c), while fructose reacts even faster with proteins in other tissues—muscles, joints, and neurons—where the damage can’t be easily tracked. Both sugars drive the same end result: advanced glycation end-products (AGEs) that stiffen tissues, inflame vessels, and slow recovery.

At 5.7, medicine calls it prediabetes. At 6.4, diabetes. But glycation begins long before those lines get drawn. By the time A1c hits 6.0, the chemistry is already cooking—and that test still says nothing about fructose damage. High-fructose foods—soda, juice, sauces—elevate methylglyoxal, a highly reactive byproduct of sugar metabolism that rapidly binds to proteins and fats, forming crosslinks in slow-turnover tissues like collagen and neurons. Fructose acts less like food and more like a chronic toxin, elevating uric acid (a known driver of gout), compounding mitochondrial stress and fat storage, adding yet another layer beneath the iceberg. That’s damage you won’t catch in a lab—but you’ll feel it in your joints, your sleep, and your recovery.

Early metabolic decline shows up before the lab results—as soreness that lingers, recovery that stalls, and output that fades early. The solution isn’t always tweaks in the workouts; it’s adjustments in the nutrition. Just as we teach the neutral spine for movement integrity, we also teach A1c for metabolic integrity. A coach who understands glycation can see what medicine misses: performance loss as the earliest biomarker of chronic disease.

In medicine, A1c helps diagnose diabetes. For us, it’s an early warning of a looming disaster. When A1c rises, the iceberg is growing—and the danger is rising with it. Glycation is already hardening what lies below the surface, long before symptoms appear.

The iceberg isn’t inevitable—it builds with poor choices. But it can melt with better ones. For trainers, that’s the opportunity: to see A1c not as a lab number but as a coaching metric—a signal of how well the athlete’s metabolism is responding to nutritional inputs. The sooner we act, the smaller the iceberg gets.

Health outcomes aren’t random. They’re dependent on two variables: what you ate and how you trained. The path out is straightforward: Little fruit. No sugar. Off the carbs, off the couch—Less glycation. A coach who understands this can intervene sooner and restore capacity before medicine even gets involved.

Hollis Molloy is a career coach and Certified CrossFit Level 4 Trainer who served on the CrossFit HQ Seminar Staff from 2007 to 2025 and has owned CrossFit Santa Cruz since 2008. He continues his work as CrossFit Santa Cruz while expanding into MetFix Santa Cruz and serves as a member of the MetFix Academy Staff, teaching and developing education for coaches on metabolic health and performance.

Support the Broken Science Initiative.
Subscribe today →

4 Comments

  1. Miles Key January 29 2026 at 12:30 am

    A great article, thank you Hollis!

  2. Karl Thorpe January 30 2026 at 3:17 am

    Great article, really like the metaphors utilised to aid with understanding. Going to have my members read this.

  3. Hollis Molloy January 30 2026 at 4:52 pm

    This article is meant to scare you a bit, on purpose, but there is hope. If your A1C is high, you are not broken. You are getting feedback, and the best part about feedback is that you can respond to it. You do not have to throw out your training or your identity as an athlete. You just get to tighten the plan so your health matches your effort.

    Your body will start rewarding you sooner than you think. Some things turn over fast. Your gut lining refreshes in about 3 to 5 days, and shorter-term glucose markers can reflect progress in 2 to 3 weeks. Skin is more like 40 to 56 days. A1C is the longer report card, about 8 to 12 weeks, so do not panic if week two does not look dramatic yet. Stay steady. The long-game tissues take years, which is exactly why consistency wins. Small changes, repeated, are how you become the athlete who is not just fit, but durable.

  4. Albert Lu January 30 2026 at 6:57 pm

    Great explanation!

Leave A Comment

recent posts

    At the 2026 Unbreakable Health Retreat in Miami, Emily Kaplan hosted a panel with Bob Kaplan, Professor Thomas Seyfried, and Dr. Derek Lee on what it means to treat cancer as a metabolic disease. They discussed the glucose-ketone index (GKI), nutritional ketosis, and strategies aimed at restricting the fuels cancer cells depend on while considering how metabolic therapy can fit alongside standard cancer treatment.

    The conversation also addressed the practical realities patients face when trying to pursue a metabolic approach within the conventional oncology system, including questions about nutrition, repurposed drugs, inherited cancer risk, and how to evaluate different treatment options. Seyfried and Lee connected these clinical questions back to mitochondrial dysfunction, fermentation, and the metabolic vulnerabilities that may offer additional targets for cancer treatment.

    An abbreviated version of this discussion is available here, for free.

    At the 2026 Unbreakable Health Retreat in Miami, Professor Thomas Seyfried presented the case that cancer is fundamentally a mitochondrial metabolic disease rather than primarily a genetic one. He contrasts the dominant somatic mutation theory with a metabolic model in which impaired mitochondrial respiration drives a shift toward fermentation, dysregulated cell growth, and the mutations commonly associated with cancer.

    Citing the work of Otto Warburg and research from his lab at Boston College, Seyfried explains how cancer cells rely heavily on fermentable fuels—particularly glucose and glutamine—and why mitochondrial dysfunction sits upstream of many of the genetic abnormalities seen in tumors. He also discusses reactive oxygen species, altered cellular signaling, and the role of mitochondria in regulating cell growth and behavior.

    The presentation then turns to the therapeutic implications of this model. Seyfried explains strategies aimed at placing tumor cells under metabolic stress by restricting the fuels they depend on, including ketogenic metabolic therapy and approaches targeting glucose and glutamine. For Seyfried, the therapeutic target follows directly from the biology: restrict the fuels cancer cells depend on, exploit their metabolic weaknesses, and treat mitochondrial dysfunction as the central feature of the disease.

    An abbreviated version of this discussion is available here, for free.

    MetFix and BSI Members can view the full 54-minute video.

  • Metabolic health, medical education, and the case for bringing clinicians and coaches together